Hera Therapeutics Inc.

New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Dec 23, 2014
Total Offering

$2,545,018

Amount Sold

$1,745,019

Investors

19

First Sale

Dec 8, 2014

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Karl Y. Hostetler
Related Person
Michael J Sullivan
Related Person
William L. Respess
Related Person
Michael D. Cannon
Related Person
John W. Sayward
Related Person

Company

Antiva Biosciences, Inc.

c/o Janssen Laboratory Accelerator

San Diego, CA, 92121

858-342-5556

SEC Filing

0001563355-14-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free